MDM2 and breast carcinoma: MDM2 gene amplification or protein overexpression has been reported in a range of human malignancies, including dedifferentiated liposarcoma (DDLPS), breast cancer, glioblastoma, colorectal cancer, non-small-cell lung cancer (NSCLC), and urothelial carcinoma among others [14].